Oral, once daily blarcamesine significantly slowed clinical decline for early Alzheimer’s disease patients with good comparative safety profile and no associated neuroimaging adverse events Clinical benefit of blarcamesine consistently observed for both 30 mg and 50 mg treatment groups Benefits of blarcamesine on both amyloid-beta and brain volume, two underlying pathological hallmarks of Alzheimer’s disease […]
Category Archives: Pr Newswire
– Featured Research Session oral presentation highlights findings that show Lomecel-B™ improved cognitive function, quality of life, and brain volume in the treatment of mild Alzheimer’s Disease – – Study meets its key objectives to advance data supporting favorable benefit/risk profile, support target engagement, and provide additional support for the efficacy profile of Lomecel-B™ – – […]
Wnt-activated, autologous, expanded, adipose-derived stem cells administered directly into lateral ventricles of the brain via Ommaya reservoir implanted under the scalp to bypass blood brain barrier Data to be presented at the Alzheimer’s Association International Conference (AAIC), 8 a.m. EDT, July 28, 2024 NEWPORT BEACH, Calif., July 28, 2024 (GLOBE NEWSWIRE) — Regeneration Biomedical, Inc. […]
Unitywater and Cognizant embark on a five-year collaboration for ICT Support Managed Services for the water provider SYDNEY and TEANECK, N.J., July 29, 2024 /PRNewswire/ — Unitywater, a leading water utility in Queensland, has announced a 5-year collaboration with Cognizant (Nasdaq: CTSH), a global leader in technology and professional services. This relationship aims to support […]
Combining the University of Adelaide and the University of South Australia, the new Adelaide University has chosen Canvas to offer a consistent, modern learning experience for more than 60,000 students. SYDNEY, July 29, 2024 /PRNewswire/ — Instructure Holdings, Inc. (Instructure) (NYSE: INST), the leading learning ecosystem and maker of Canvas Learning Management System (LMS), announced […]
PRINCETON, N.J., July 28, 2024 /PRNewswire/ — Luye Pharma Group (Luye Pharma), an international pharmaceutical company dedicated to the R&D, manufacturing and sales of innovative medications, today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s ERZOFRI® (paliperidone palmitate) extended-release injectable suspension, for treating schizophrenia in adults and for treating schizoaffective […]
NEWTON, Mass., July 28, 2024 (GLOBE NEWSWIRE) — Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer’s disease (AD), today announced new findings from its Phase 1 INTERCEPT-AD study of sabirnetug (ACU193). The research highlights the experiences of patients […]
SHANGHAI, July 28, 2024 /PRNewswire/ — On 26 July 2024, the DreamSmart AI Ecological Pavilion officially landed at the 2024 China International Digital Interactive Entertainment Exhibition (2024 ChinaJoy, Shanghai • New International Expo Center Snapdragon Theme Pavilion E4-05 Booth), presenting the latest AI intelligent technology products and multi-field ecological achievements in a new integrated exhibition format […]
The Beijing Central Axis is now ready for digital visitors from around the world SHENZHEN, China, July 27, 2024 /PRNewswire/ — Tencent (0700.HK) today launched the largest virtual urban historical landscape created to date called Microcosm, an immersive experience that brings Beijing’s Central Axis to life online. The project launch coincides with the addition of the […]
All dollar amounts reflected in Canadian dollars unless otherwise stated. VANCOUVER, British Columbia, July 26, 2024 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) (the “Company”), a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies, announces that, further to the press releases dated May 23, 2024, June 20, 2024, […]
